Lasarrus Competitors and Similar CompaniesClear all

Lasarrus's competitors and similar companies include Neuraptive Therapeutics, ViewRay, Elekta and Brainlab.

	Lasarrus Lasarrus Clinic and Research Center is a company that develops solutions for the remote monitoring of chronic obstructive pulmonary disease (COPD).	Neuraptive Therapeutics Neuraptive is bringing therapeutic technology for the acute surgical repair of injured peripheral nerves.	ViewRay ViewRay is a company that designs, manufactures, and markets MRIdian, an MRI-guided radiation therapy system.	Elekta Elekta is a medical device company that manufactures radiotherapy solutions for cancer care and brain disorders.	Brainlab Brainlab is a company that develops, manufactures, and markets software-driven medical technology.
Founding Date	Founding Date 2013	Founding Date 2016	Founding Date 2004	Founding Date 1972	Founding Date 1989
Type	Type Private	Type Private	Type Public	Type Public	Type Private
Tags	Tags Healthcare medtech monitoring therapy	Tags Technology medtech surgical solutions therapy	Tags Technology medtech oncology therapy	Tags Technology medtech oncology therapy	Tags Technology biotech medtech therapy
Locations	Locations Baltimore, US HQ	Locations Lafayette, US HQ Philadelphia, US	Locations Oakwood Village, US HQ Mountain View, US	Locations Stockholm, SE HQ North Sydney, AU Innsbruck, AT Zaventem, BE São Paulo, BR Montréal, CA Beijing, CN see more	Locations Munich, DE HQ Melbourne, AU Sydney, AU São Paulo, BR Beijing, CN Paris, FR Heidelberg, DE see more
Employees	Employees 717% increase	Employees 15	Employees 29510% increase	Employees 4,541	Employees 1,9839% decrease
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 2.4 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $102.2m (FY, 2022)	Revenue (est.) kr18b (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $92.2m (FY, 2022)	Cost of goods kr11.1b (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit $10m (FY, 2022)	Gross profit kr6.9b (FY, 2025)	Gross profit N/A
Net income	Net income N/A	Net income N/A	Net income ($107.3m) (FY, 2022)	Net income kr240m (FY, 2025)	Net income N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 11.5m (over 7 years ago)	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 7.3m (over 19 years ago)
Total funding raised	Total funding raised N/A	Total funding raised $ 12.5m	Total funding raised $ 84.8m	Total funding raised N/A	Total funding raised N/A